Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
18.42
+0.09 (0.49%)
Dec 26, 2024, 3:07 PM EST - Market open
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.13 billion as of December 26, 2024. Its market cap has increased by 124.47% in one year.
Market Cap
1.13B
Enterprise Value
1.06B
1-Year Change
124.47%
Ranking
Category
Stock Price
$18.42
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.13B, an increase of 2,062.48%. That is a compound annual growth rate of 42.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 1.13B | 67.52% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.14B |
| CareDx | 1.12B |
| Innoviva | 1.11B |
| ARS Pharmaceuticals | 1.09B |
| Ardelyx | 1.08B |
| ANI Pharmaceuticals | 1.06B |
| Gyre Therapeutics | 1.05B |
| Rocket Pharmaceuticals | 1.04B |